Alnylam Pharmaceuticals reported $-188614000 in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -46063000 15.2M
Agios Pharmaceuticals AGIO:US USD -99172000 8.08M
Alnylam Pharmaceuticals ALNY:US USD -188614000 69.43M
Amgen AMGN:US USD 2.23B 436M
Arrowhead Research ARWR:US USD -42134000 41.7M
Avrobio Inc AVRO:US USD -25257000 2.27M
Biocryst Pharmaceuticals BCRX:US USD -46311000 28.87M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -86480000 14.28M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
Mirati Therapeutics MRTX:US USD -211723000 25.28M
Moderna Inc MRNA:US USD 1.58B 414M
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NVS:US USD 3.1B 228M
Ptc Therapeutics PTCT:US USD -166957000 98.77M
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Sangamo Biosciences SGMO:US USD -55392000 498K
Sarepta Therapeutics SRPT:US USD -106833000 24.52M
Takeda 4502:JP JPY 146.99B 42.55B
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
Vertex Pharmaceuticals VRTX:US USD 1.04B 89.7M
Xencor XNCR:US USD -42593000 4.24M
YTE INCY:US USD 93.36M 24.89M